Literature DB >> 21045160

Retraction: CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejection.

Kevin D Pavelko, Michael J Hansen, Larry R Pease.   

Abstract

Entities:  

Year:  2010        PMID： 21045160      PMCID： PMC4384814          DOI： 10.1158/0008-5472.CAN-10-3463

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  1 in total

1.  CTL activation using the natural low-affinity epitope 222-229 from tyrosinase-related protein 1 leads to tumor rejection.

Authors:  Kevin D Pavelko; Michael J Hansen; Larry R Pease
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.